Novavax, Inc. (NVAX)
7.46
-0.36
(-4.66%)
USD |
NASDAQ |
Jul 24, 16:00
7.50
+0.04
(+0.54%)
After-Hours: 17:35
Novavax Total Return Level : 7.825 for July 23, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| July 23, 2026 | 7.825 |
| July 22, 2026 | 7.91 |
| July 21, 2026 | 8.075 |
| July 20, 2026 | 7.88 |
| July 17, 2026 | 8.21 |
| July 16, 2026 | 8.24 |
| July 15, 2026 | 8.43 |
| July 14, 2026 | 8.42 |
| July 13, 2026 | 8.91 |
| July 10, 2026 | 9.33 |
| July 09, 2026 | 9.40 |
| July 08, 2026 | 9.35 |
| July 07, 2026 | 9.46 |
| July 06, 2026 | 9.35 |
| July 02, 2026 | 9.74 |
| July 01, 2026 | 9.46 |
| June 30, 2026 | 9.42 |
| June 29, 2026 | 9.36 |
| June 26, 2026 | 8.88 |
| June 25, 2026 | 8.56 |
| June 24, 2026 | 8.90 |
| June 23, 2026 | 9.00 |
| June 22, 2026 | 9.00 |
| June 18, 2026 | 9.13 |
| June 17, 2026 | 9.50 |
| Date | Value |
|---|---|
| June 16, 2026 | 9.20 |
| June 15, 2026 | 9.21 |
| June 12, 2026 | 8.88 |
| June 11, 2026 | 9.03 |
| June 10, 2026 | 8.56 |
| June 09, 2026 | 8.67 |
| June 08, 2026 | 8.62 |
| June 05, 2026 | 9.49 |
| June 04, 2026 | 10.19 |
| June 03, 2026 | 10.20 |
| June 02, 2026 | 10.21 |
| June 01, 2026 | 10.51 |
| May 29, 2026 | 10.97 |
| May 28, 2026 | 10.32 |
| May 27, 2026 | 11.09 |
| May 26, 2026 | 10.46 |
| May 22, 2026 | 9.21 |
| May 21, 2026 | 8.98 |
| May 20, 2026 | 9.27 |
| May 19, 2026 | 8.90 |
| May 18, 2026 | 8.93 |
| May 15, 2026 | 9.06 |
| May 14, 2026 | 9.35 |
| May 13, 2026 | 9.23 |
| May 12, 2026 | 9.62 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Moderna, Inc. | 57.02 |
| Pfizer Inc. | 82.22 |
| Agenus, Inc. | 6.19 |
| Fate Therapeutics, Inc. | 2.52 |
| Recursion Pharmaceuticals, Inc. | 3.01 |